O-GlcNAcylation is a key post-translational modification that modifies the functions of
proteins. Associations between O-GlcNAcylation, shorter survival of
cholangiocarcinoma (CCA) patients, and increased migration/invasion of CCA cell lines have been reported. However, the specific O-GlcNAcylated
proteins (OGPs) that participate in promotion of CCA progression are poorly understood. OGPs were isolated from human CCA cell lines, KKU-213 and KKU-214, using a click chemistry-based enzymatic labeling system, identified using LC-MS/MS, and searched against an OGP database. From the proteomic analysis, a total of 21 OGPs related to
cancer progression were identified, of which 12 have not been previously reported. Among these,
hnRNP-K, a multifaceted
RNA- and
DNA-binding protein known as a
pre-mRNA-
binding protein, was one of the most abundantly expressed, suggesting its involvement in CCA progression. O-GlcNAcylation of
hnRNP-K was further verified by anti-OGP/anti-
hnRNP-K immunoprecipitations and
sWGA pull-down assays. The perpetuation of CCA by
hnRNP-K was evaluated using
siRNA, which revealed modulation of
cyclin D1, XIAP, EMT markers, and MMP2 and MMP7 expression. In native CCA cells,
hnRNP-K was primarily localized in the nucleus; however, when O-GlcNAcylation was suppressed,
hnRNP-K was retained in the cytoplasm. These data signify an association between nuclear accumulation of
hnRNP-K and the migratory capabilities of CCA cells. In human CCA tissues, expression of nuclear
hnRNP-K was positively correlated with high O-GlcNAcylation levels, metastatic stage, and shorter survival of CCA patients. This study demonstrates the significance of O-GlcNAcylation on the nuclear translocation of
hnRNP-K and its impact on the progression of CCA.